Welcome to Elenvia Labs
About
Elenvia Labs is a biotechnology company focused on the development of peptide-based innovations for skin applications.
Our work combines bioengineering, molecular science, and skin biology to translate scientific research into evidence-based formulations and functional biomolecular technologies.
Current development activities are centered around patented peptide research connected to Imperial College London, with initial applications focused on next-generation cosmetic products designed to support skin function and healthy aging.
Our Origin
Elenvia Labs was established as an Imperial College spinout following the development of innovative concepts in biomolecular engineering and skin-related research.
The company is currently supported through the project PRE-SEED/0824/0266, which is implemented under the programme of social cohesion “THALIA 2021-2027” co-funded by the European Union, through the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation.
This support enables the continued research, development, and validation of our peptide-based technologies and early-stage product innovation.
